<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11634">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01958606</url>
  </required_header>
  <id_info>
    <org_study_id>HIT in chronic stroke</org_study_id>
    <nct_id>NCT01958606</nct_id>
  </id_info>
  <brief_title>High Intensity Interval Training in Chronic Stroke</brief_title>
  <acronym>HIT</acronym>
  <official_title>High Intensity Interval Training in Chronic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Physical Therapy Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Cincinnati Provost's Pilot Research Program</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cincinnati</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to compare the effectiveness of high intensity interval
      training (HIT) and traditional aerobic training for persons with stroke.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in peak aerobic capacity (VO2-peak)</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in gait velocity (10 meter walk test)</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in 6-Minute Walk Test</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in daily physical activity (Activity Monitor)</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in gait economy (mean oxygen uptake at comfortable walking speed)</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Stroke Impact Scale</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in Self-Efficacy and Outcome Expectations for Exercise Scale</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Change in Montreal Cognitive Assessment</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Change in gait kinematics/kinetics from baseline to 4 weeks</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>3D motion capture and force plates</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in gait kinematics/kinetics from baseline to POST session 1</measure>
    <time_frame>Baseline and after session 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>3D motion capture and force plates</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in gait kinematics/kinetics during session 1</measure>
    <time_frame>During session 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>3D motion capture and force plates</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in transcranial magnetic stimulation (TMS) responses from baseline to 4 weeks</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Primary variable is motor threshold (MT). Secondary variables include: motor evoked potential amplitude/latency, corticomotor map size and volume and intracortical inhibition</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in transcranial magnetic stimulation (TMS) responses associated with training session 2</measure>
    <time_frame>Before and after training session 2</time_frame>
    <safety_issue>No</safety_issue>
    <description>Primary variable is motor threshold (MT). Secondary variables include: motor evoked potential amplitude/latency and intracortical inhibition</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in transcranial magnetic stimulation (TMS) responses associated with training session 12</measure>
    <time_frame>Before and after training session 12</time_frame>
    <safety_issue>No</safety_issue>
    <description>Primary variable is motor threshold (MT). Secondary variables include: motor evoked potential amplitude/latency and intracortical inhibition</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>High-intensity interval training (HIT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treadmill exercise using bursts of concentrated effort alternated with recovery periods</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional aerobic training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Moderate intensity continuous aerobic exercise on a treadmill</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High-intensity interval training (HIT)</intervention_name>
    <description>Treadmill exercise using bursts of concentrated effort alternated with recovery periods</description>
    <arm_group_label>High-intensity interval training (HIT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Traditional Aerobic Training</intervention_name>
    <description>Moderate intensity continuous aerobic exercise on a treadmill</description>
    <arm_group_label>Traditional aerobic training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1) age 35-90 years

          -  2) unilateral stroke experienced &gt;6 months prior to enrollment

          -  3) gait speed &lt;1.0 m/s

          -  4) able to walk 10m overground with assistive devices as needed and no physical
             assistance

          -  5) able to walk 3 minutes on the treadmill at &gt;.13m/s (0.3mph) with no aerobic
             exercise contraindications

          -  6) stable cardiovascular condition (American Heart Association class B, allowing for
             aerobic capacity &lt;6 metabolic equivalents)

          -  7) discharged from formal rehabilitation

        Exclusion Criteria:

          -  1) significant resting ECG abnormalities

          -  2) evidence of significant arrhythmia or myocardial ischemia on treadmill ECG stress
             test

          -  3) hospitalization for cardiac or pulmonary disease within 3 months

          -  4) pacemaker or implanted defibrillator

          -  5) lower extremity claudication

          -  6) Mini-Mental State Exam &lt;23/30

          -  7) severe lower extremity spasticity (Ashworth &gt;2)

          -  8) lower extremity weight bearing pain &gt;4/10 on visual analogue scale

        For the transcranial magnetic stimulation substudy, additional exclusions will also be
        applied. These include large cerebral infarcts or other structural defects with the
        potential to increase seizure risk, uncontrolled seizures, metal implants and previous
        craniotomy.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brett Kissela, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cincinnati</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kari Dunning, PhD, PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cincinnati</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Johnny Wilkerson, BS</last_name>
    <phone>513-259-1597</phone>
    <email>jowilkerson@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pierce Boyne, PT, DPT, NCS</last_name>
    <phone>513-264-1186</phone>
    <email>pierce.boyne@uc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierce Boyne, PT, DPT, NCS</last_name>
      <phone>513-264-1186</phone>
    </contact>
    <investigator>
      <last_name>Brett M Kissela, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kari Dunning, PhD, PT</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierce Boyne, PT, DPT, NCS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Carl, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Myron Gerson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jane Khoury, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 7, 2013</lastchanged_date>
  <firstreceived_date>October 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cincinnati</investigator_affiliation>
    <investigator_full_name>Brett Kissela</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Rehabilitation</keyword>
  <keyword>Exercise</keyword>
  <keyword>Intensity</keyword>
  <keyword>Gait</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
